Results 181 to 190 of about 27,602 (209)

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Clinical and Applied Thrombosis/Hemostasis, 2006
Steven R Deitcher, Craig M Kessler, Geno J Merli   +2 more
exaly  

Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial

Lancet, The, 2010
Michael Rud Lassen, Gary E Raskob, Alexander S Gallus   +2 more
exaly  

Administering an enoxaparin injection

Nursing, 2008
openaire   +2 more sources

Apixaban versus enoxaparin for thromboprophylaxis after hip or knee replacement

Journal of Bone and Joint Surgery: British Volume, 2012
M R Lassen
exaly  

Increased major bleeding risk in patients with kidney dysfunction receiving enoxaparin: a meta-analysis

European Journal of Clinical Pharmacology, 2011
Frieder Keller, Keller Frieder
exaly  

Enoxaparin

2013
openaire   +1 more source

Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis

European Heart Journal, 2007
Sabina A Murphy, C Michael Gibson, David A Morrow   +2 more
exaly  

Pharmacodynamic and Pharmacokinetic Properties of Enoxaparin

Clinical Pharmacokinetics, 2012
, Qing Ma, Fareed Jawed
exaly  

Delayed-type hypersensitivity to subcutaneous enoxaparin

Allergy: European Journal of Allergy and Clinical Immunology, 1998
Cristina Martinez, A Armentia
exaly  

ENOXAPARIN

2004
openaire   +1 more source